Sinopharm Group Co's market cap is currently $62.53B. The company's EPS TTM is HK$2.999; its P/E ratio is 6.68; and it has a dividend yield of 4.89%. Sinopharm Group Co is scheduled to report earnings on March 21, 2025, and the estimated EPS forecast is HK$1.57. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 596.57B	¥ 552.15B	¥ 521.05B	¥ 456.41B	¥ 425.27B
Gross Profit	¥ 48.51B	¥ 47.43B	¥ 44.05B	¥ 40.32B	¥ 37.53B
Operating Income	¥ 22.32B	¥ 20.60B	¥ 19.71B	¥ 17.76B	¥ 16.14B
EBITDA	¥ 26.90B	¥ 26.25B	¥ 24.68B	¥ 22.62B	¥ 20.32B
Net Income	¥ 9.05B	¥ 14.35B	¥ 13.06B	¥ 12.10B	¥ 10.62B
Balance Sheet
Cash & Short-Term Investments	¥ 63.81B	¥ 55.22B	¥ 43.54B	¥ 50.22B	¥ 39.19B
Total Assets	¥ 383.39B	¥ 364.78B	¥ 335.41B	¥ 311.24B	¥ 269.89B
Total Debt	¥ 73.78B	¥ 69.59B	¥ 68.37B	¥ 68.53B	¥ 55.14B
Net Debt	¥ 9.97B	¥ 14.37B	¥ 24.84B	¥ 18.35B	¥ 15.95B
Total Liabilities	¥ 263.08B	¥ 254.71B	¥ 235.76B	¥ 221.29B	¥ 192.95B
Stockholders' Equity	¥ 74.58B	¥ 68.07B	¥ 61.89B	¥ 56.36B	¥ 47.42B
Cash Flow
Free Cash Flow	¥ 14.84B	¥ 18.55B	¥ 7.05B	¥ 9.07B	¥ 16.23B
Operating Cash Flow	¥ 17.17B	¥ 20.96B	¥ 9.31B	¥ 11.15B	¥ 18.78B
Investing Cash Flow	¥ -944.53M	¥ -3.59B	¥ -1.27B	¥ -2.20B	¥ -6.80B
Financing Cash Flow	¥ -7.64B	¥ -5.69B	¥ -14.69B	¥ 2.03B	¥ -13.08B

Currency in CNY

Sinopharm Group Co Earnings and Revenue History

Income Statement >

Sinopharm Group Co Debt to Assets

Balance Sheet >

Sinopharm Group Co Cash Flow

Cash Flow >

Sinopharm Group Co Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing